To investigate safety issues related to use of haploidentical highly purified CD133+ hematopoietic cells in patients with SCID [clinicaltrials_resource:d0781a4f8f46dad56c290aa6b2045a39]
St. Jude Children's Research Hospital
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
To investigate safety issues related to use of haploidentical highly purified CD133+ hematopoietic cells in patients with SCID [clinicaltrials_resource:d0781a4f8f46dad56c290aa6b2045a39]
St. Jude Children's Research Hospital
Bio2RDF identifier
d0781a4f8f46dad56c290aa6b2045a39
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d0781a4f8f46dad56c290aa6b2045a39
measure [clinicaltrials_vocabulary:measure]
To investigate safety issues r ...... ic cells in patients with SCID
description
St. Jude Children's Research Hospital
identifier
clinicaltrials_resource:d0781a4f8f46dad56c290aa6b2045a39
title
To investigate safety issues r ...... ic cells in patients with SCID
@en
type
label
To investigate safety issues r ...... 81a4f8f46dad56c290aa6b2045a39]
@en